Updates

Procter & Gamble Hygiene and Health Care Limited CIN: L24239MH1964PLC012971 Registered Office: P&G Plaza Cardinal Gracias Road, Chakala Andheri (E), Mumbai 400 099 Tel: (91-22) 6958 6000 Fax: (91-22) 6958 7337 Website: in.pg.com August 17, 2026 To, To, The Corporate Relations Department The Listing Department The BSE Limited The National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001 Mumbai – 400051 Ref:- Scrip Code:- 500459 Ref:- Scrip Code:- PGHH Dear Sir / Madam, Sub: Annual Report and Notice calling the 62nd Annual General Meeting of the Company for the Financial Year ended March 31, 2026 Please find enclosed Annual Report and Notice calling the 62nd Annual General Meeting (AGM) of the Company for the Financial Year ended March 31, 2026. In accordance with the Circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India, the Annual Report for the Financial Year 2025-26, including the Notice of AGM have been sent in electronic mode to Members, today, i.e, Monday, August 17, 2026, whose e-mail address is registered with the Company. A physical letter with link to the Annual Report and notice calling the 62nd AGM was sent to shareholders whose email address is not updated. The copy of the Notice along with the Annual Report enclosed herewith and is also available on the Company’s website: https://in.pg.com/india-investors/pghh/shareholder-info/info/. Further, it may be noted that shareholders who would like to express their views/have questions, may register themselves as a speaker by sending their request in advance mentioning their name, demat account number/ folio number, e-mail id, mobile number at investorpghh.im@pg.com or machado.f.1@pg.com from the date of this notice up to September 1, 2026 (5:00 p.m. IST). Those Members who have registered themselves as a speaker will only be allowed to express their views/ask questions during the AGM. The Company reserves the right to restrict the number of speakers and number of questions depending on the availability of time for the AGM. Kindly take the same on record and oblige. Thanking you, Yours faithfully, For Procter & Gamble Hygiene and Health Care Limited Flavia Machado Authorized Signatory Procter & Gamble Hygiene & Health Care Limited Annual Report 2025-26 CONTENT Corporate Information 1 Board of Directors 2 About the Company 4 Financial Highlights 6 Managing Director's Statement 7 Director’s Report 8 Business Responsibility & Sustainability Report 19 Corporate Social Responsibility Report 48 Corporate Governance Report 53 Financial Statements 78 CORPORATE INFORMATION Board of Directors & Key Managerial Personnel Mr. Chittranjan Dua Chairman and Independent Director Mr. Kumar Venkatasubramanian Managing Director Mr. Gurcharan Das Independent Director Mr. Krishnamurthy Iyer Independent Director Dr. Ashima Goyal Independent Director Mr. Pramod Agarwal Non-Executive Director Ms. Sonali Dhawan Non-Executive Director Mr. Ghanashyam Hegde Non-Executive Director Ms. Srividya Srinivasan Executive Director and Chief Financial Officer (from July 1, 2026) Registered Office Auditors Procter & Gamble Hygiene and Statutory Auditor: Health Care Limited Kalyaniwalla & Mistry LLP (CIN: L24239MH1964PLC012971) Chartered Accountants P&G Plaza, Cardinal Gracias Road, Cost Auditor: Chakala, Andheri (East), Ashwin Solanki & Associates Mumbai – 400 099 Cost Accountants Tel. No: (022) 6958 6000 Secretarial Auditor: Investor helpline No: 86575 00524 M. K. Saraf & Associates LLP Website: in.pg.com Company Secretaries Registrar & Share Transfer Agents Listed on Stock Exchanges: MUFG Intime India Private Limited BSE Limited C-101, 247 Park, L.B.S. Marg, Vikhroli (West), National Stock Exchange of India Limited Mumbai – 400 083 Tel. No: (022) 4918 6279 E-mail Id: investor.helpdesk@in.mpms.mufg.com Certain statements in this report, except for the historical data, may contain forward-looking statements, including words, phrases, numbers that set forth anticipated results based on management’s current plans and assumptions. Forward looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves. The Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except to the extent required by law. PB Annual Report 2025-26 Annual Report 2025-26 1 BOARD OF DIRECTORS Mr. Chittranjan Dua, Mr. Krishnamurthy Iyer, Mr. Gurcharan Das, Chairman and Independent Independent Director Independent Director Director Mr. Iyer is a member of Institute of Mr. Das is a distinguished Mr. Dua is the founding Chartered Accountants of India and author and public intellectual. partner of Dua Associates and the Institute of Company Secretaries He was formerly CEO of Procter is currently chairman of the of India. Mr. Iyer is a long term & Gamble India and Managing firm and engaged in providing global professional with wide and Director of Procter & Gamble strategic advice and direction varied experience in functional and Worldwide (Strategic Planning). for its further growth and leadership roles in various industries He graduated in philosophy with development. His experience in different countries. Currently, honours from Harvard University, and expertise encompass a he is the Managing Partner of an where he was later inducted in Phi broad range of areas including Investment Management company, Beta Kappa for 'high attainments corporate and commercial law, Rational Equity Partners LLP. During in liberal scholarship'. He is today corporate finance, securities law, a career spanning over four decades, one of India’s most celebrated infrastructure, public policy and he has worked in senior positions authors and thinkers, best administration, governance and and as CEO in various companies known for two iconic, bestsellers: ethics, land acquisition, power such as Walmart, AS Watsons, ANZ The Difficulty of Being Good projects, foreign investments Grindlays Bank and Piramyd Retail and India Unbound, which and collaborations, privatization in multiple geographies in India as have shaped public discourse of public sector undertakings, well as overseas. During the stint on India’s economic and social mergers and acquisitions and in Walmart as President & CEO of transformation. His newspaper exchange control regulations. Walmart India, he played a pivotal columns are among the most role in growing the brick & mortar widely read in India. and digital footprint of Walmart in India. Dr. Ashima Goyal, Independent Director Dr. Goyal is an M.A. and M. Phil from Delhi School of Economics. She also has a Ph.D from Bombay University on thesis titled ‘The Short-Run Behaviour of the Indian Economy and its Implications for Long-run growth.’ Dr. Goyal is affiliated with the Indira Gandhi Institute of Development Research and EGROW Foundation. She is widely published in institutional and open economy macroeconomics, international finance and governance, with more than a hundred articles in national and international journals. She has also authored and edited a number of books including Macroeconomics and Markets in Developing and Emerging Economies and A Concise Handbook of the Indian Economy in the 21st Century. Dr. Goyal has provided consultancy to ADB, DEA, GDN, UNDP, RBI, UN ESCA [Showing first 8,000 characters — download PDF for full document]